Röchling Medical Manufacturing and R&D Services for Pharmaceutical Packaging

Röchling Medical offers customers a wide range of products in the field of plastics processing and precision assembly technologies for the medical, diagnostics and pharmaceutical industries.

As part of the Röchling Group, this medical division provides high-quality products and services in the drug delivery devices, primary packaging, surgical instruments and diagnostics disposables categories.

The company also provides primary packaging in veterinary medicine.

Custom manufacturing for pharmaceutical and life science industry

Röchling Medical provides a comprehensive range of custom product manufacturing services to the pharmaceutical and life science industries, implementing various production packaging solutions such as blow moulding (injection, extrusion, multi-layer extrusion, and injection stretch-blow moulding), assembly and tooling.

The company supports pharmaceutical and medical device companies from concept development and manufacturing to testing, validation, and packaging.

It supports clients in maximising return on investment (ROI) and offers a variety of options such as manual, semi-automated, and automated cleanroom assembly and testing.

In addition, customers benefit from Röchling Medical’s global infrastructure and sourcing capabilities.

Multi-particulate drug delivery system

Sympfiny™ is an advanced oral delivery system for administering drugs in multi-particulate, dry powder or microsphere form.

It consists of a syringe connected to a drug container, which adopts a technique that is reliably used with liquid drugs. The syringe has an integrated dosage mechanism.

Child-resistant closures (CRC)

Röchling Medical offers a wide range of tamper-evident closures with features such as desiccant chambers, gaskets and liners to meet customer requirements.

Being ISO: 8317 certified, the company’s research and development (R&D) department designed the child-resistant and senior-friendly CRC caps using its extensive expertise.

Plastic containers for pharmaceutical primary packaging

One of Röchling Medical’s core competencies is the development and manufacturing of high-quality plastic primary packaging for the pharmaceuticals, diagnostics and life science sectors.

The company provides vials made from cyclic olefin polymers (COP) as a substitute for glass. They maintain the transparency and barrier properties of glass, while also being lightweight and resilient.

In addition, the COP vials can be used for parenteral formulations containing proteins, and are suitable for autoclaving and all common sterilisation processes.

Life science devices, prototyping and process development

As a producer of devices for the life sciences sector, Röchling Medical collaborates with some of the world‘s largest original equipment manufacturers (OEM) in the industry to acquire an in-depth understanding of the complex requirements.

Röchling Medical proves its excellence in engineering when it comes to rapid prototyping and process development, and it provides validation services for leading medical device companies.

Minimally invasive surgery

Röchling Medical manufactures minimally invasive surgical devices such as:

  • Cannulas and obturators
  • Laparoscopic jaws
  • Vessel sealing devices
  • Intravenous (IV) components
  • Trocar components

Production under cleanroom conditions

Röchling Medical has more than 8,000m² of cleanroom space for plastic production and assembly processes. These areas comply with stringent industry requirements and are subject to constant monitoring and regular internal and regular audits.

The company also frequently trains employees on the latest regulatory requirements.

As a system supplier, Röchling Medical offers common sterilisation methods via partner companies and meets clients’ purity requirements beyond cleanroom quality.

R&D and new product innovation

Röchling Medical has its own R&D department to ensure clients achieve objectives and requests are met in a precise, functional and creative manner.

The company works closely with international research institutes and universities to provide high-quality R&D services related to new materials, procedures and innovations.

Röchling Medical utilises an ISO: 15378 certified new product innovation (NPI) process for custom product development for numerous applications. Its validation processes meet good manufacturing practices (GMP), US Food and Drug Administration (FDA) and ISO: 13485 regulatory requirements.

Make an enquiry

Press Release

Röchling Medical to Attend Pharmapack, Paris

Röchling Medical has announced it will be showcasing its products and services at the Propack Paris Expo. 

White Papers

Manufacturing Services for Pharmaceutical, Medical and Diagnostics Sectors

Röchling Medical Division supplies contract manufacturing services relating to plastic processing and precision assembly technology with pharmaceutical, medical, and diagnostics industries.

Röchling Medical Neuhaus GmbH & Co. KG

Röchling Medical Images

Related Projects

Press Release

16 January 2019

Röchling Medical has announced it will be showcasing its products and services at the Propack Paris Expo. 

Read more
5 October 2018

Röchling Medical has announced it will be attending two key pharmaceutical industry events (CPhI Worldwide and Pharmtech Expo) to showcase its diagnostics and life science solutions.

Read more
20 September 2018

Röchling Medical has ceremoniously marked the expansion of its site in Neuhaus am Rennweg, Germany.

Read more
14 September 2018

Röchling continued its record of success in the 2016 financial year and Q1 2017, increasing its sales by 15.1% to €474.6 million in the first three months of 2017.

Read more
11 September 2018

Röchling Advent Tool & Mold has acquired the American medical technology specialist Precision Medical Products (PMP) based in Denver, Pennsylvania, US.

Read more
4 September 2018

It is often difficult to orally administer the correct amount of drugs accurately and safely to children due to their bitter taste.

Read more
24 August 2018

The Röchling Group has completed another step in its growth strategy. Subject to approval by the Cartel Office, the plastics specialist from Mannheim has acquired Baden-Württemberg-based medical and industrial technology provider FRANK plastic.

Read more
23 August 2018

Röchling’s CEO Hanns-Peter Knaebel joined the executive board on 1 October 2017. He is also in charge of medicine as vice-chairman.

Read more

Regional Offices

Röchling Medical Neuhaus GmbH & Co. KG
Röchling Medical Brensbach GmbH

Brensbach Höchster Str. 100

64395 Brensbach


Röchling Medical Rochester

Rochester Holleder Technology Park, 999 Ridgeway Ave.

14615 Rochester

New York (NY)

United States of America

Roechling Medical Lancaster LCC

Denver (PA) 44 Denver Road

17517 Denver (PA)


United States of America

Roechling Engineering Plastics (Suzhou) Co., Ltd

Suzhou 448, Chang Yang Street – Suzhou Industrial Park

215024 Suzhou


+86 512 6265 2899

Go Top